Solara Active Pharma Sciences (NSE:SOLARA) Other Operating Expense : ₹4,870 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences Other Operating Expense?

Solara Active Pharma Sciences's Other Operating Expense for the three months ended in Dec. 2024 was ₹1,323 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹4,870 Mil.

Solara Active Pharma Sciences's quarterly Other Operating Expense declined from Jun. 2024 (₹1,451 Mil) to Sep. 2024 (₹1,391 Mil) and declined from Sep. 2024 (₹1,391 Mil) to Dec. 2024 (₹1,323 Mil).

Solara Active Pharma Sciences's annual Other Operating Expense declined from Mar. 2022 (₹5,140 Mil) to Mar. 2023 (₹4,775 Mil) but then increased from Mar. 2023 (₹4,775 Mil) to Mar. 2024 (₹5,395 Mil).

Solara Active Pharma Sciences Other Operating Expense Historical Data

The historical data trend for Solara Active Pharma Sciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Other Operating Expense Chart

Solara Active Pharma Sciences Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

4,217.00

4,743.60

5,140.10

4,774.80

5,394.50

Solara Active Pharma Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															1,840.70	704.90	1,450.70	1,390.90	1,323.10

Solara Active Pharma Sciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,870 Mil.

Solara Active Pharma Sciences Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Solara Active Pharma Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (NSE:SOLARA) » Definitions » Other Operating Expense

Traded in Other Exchanges

SOLARAPP:India 890202:India 541540:India

Address

27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127

Website

https://www.solara.co.in

Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines